Athira Pharma (ATHA)
(Delayed Data from NSDQ)
$0.46 USD
0.00 (0.41%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $0.47 +0.01 (1.10%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.61 | 0.00% |
Earnings Summary
For their last quarter, Athira Pharma (ATHA) reported earnings of -$0.70 per share, beating the Zacks Consensus Estimate of $-0.75 per share. This reflects a positive earnings surprise of 6.67%. Look out for ATHA's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.61 per share, reflecting a year-over-year increase of 29.89%.
Earnings History
Price & Consensus
Zacks News for ATHA
ATHA Stock Tanks as Alzheimer's Study Fails to Meet Primary Goal
ATHA: What are Zacks experts saying now?
Zacks Private Portfolio Services